Human papillomavirus infection and non-oropharyngeal head and neck cancers: an umbrella review of meta-analysis

Eur Arch Otorhinolaryngol. 2023 Sep;280(9):3921-3930. doi: 10.1007/s00405-023-08027-4. Epub 2023 May 22.

Abstract

Objective: The causative and prognostic roles of human papillomavirus (HPV) in non-oropharyngeal squamous cell carcinoma of the head and neck are uncertain. This umbrella review assessed the strength and quality of evidence and graded the evidence derived from published meta-analyses on this subject.

Data sources: MEDLINE, Embase, and the Cochrane Library were searched. Meta-analyses of observational studies and randomized trials were included.

Review methods: Evidence of association was graded according to the established criteria: strong, highly suggestive, suggestive, weak, or not significant.

Results: 15 meta-analyses were evaluated. The association with HPV was highly suggestive of oral (OR = 2.40, [1.87-3.07], P < 0.00001) and nasopharyngeal cancers (OR = 17.82 [11.20-28.35], P < 0.00001). Improved survival emerged only in hypopharyngeal carcinoma and was confirmed in studies in which only p16 + cancers were considered.

Conclusion: HPV infection may increase the risk of oral cavity and nasopharyngeal cancer. However, the prognosis was not influenced, except in hypopharyngeal carcinoma.

Keywords: Cancer; HPV; Head and neck; Meta-analysis; Non-oropharyngeal; Umbrella review.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Head and Neck Neoplasms* / complications
  • Human Papillomavirus Viruses
  • Humans
  • Mouth / pathology
  • Nasopharyngeal Neoplasms*
  • Oropharyngeal Neoplasms* / pathology
  • Papillomaviridae
  • Papillomavirus Infections* / complications